Paper36713447
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Whelan JT and 26 others. Front Immunol, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX. Papers, record 36713447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36713447
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Poxviridae | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Genetic Vectors | |
| Vaccinia virus | |
| Immunotherapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CIHR | Canada | PubMed |
Source PubMed
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31011628 | The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism. | Mol Ther Oncolytics | 2019 | https://conductscience.org/library/papers/31011628 | PubMed |
| 2 | 23769666 | Structure and signaling mechanism of a zinc-sensory diguanylate cyclase. | Structure | 2013 | https://conductscience.org/library/papers/23769666 | PubMed |
| 3 | 36015016 | Poxvirus Recombination. | Pathogens | 2022 | https://conductscience.org/library/papers/36015016 | PubMed |
| 4 | 32668227 | Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. | Immunity | 2020 | https://conductscience.org/library/papers/32668227 | PubMed |
| 5 | 27043414 | S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3. | Nat Immunol | 2016 | https://conductscience.org/library/papers/27043414 | PubMed |
| 6 | 29676720 | Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol. | J Gen Virol | 2018 | https://conductscience.org/library/papers/29676720 | PubMed |
| 7 | 2587253 | Vaccinia virus encodes a polypeptide with DNA ligase activity. | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2587253 | PubMed |
| 8 | 11119568 | Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity. | J Virol | 2001 | https://conductscience.org/library/papers/11119568 | PubMed |
| 9 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 10 | 25741005 | Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system. | J Virol | 2015 | https://conductscience.org/library/papers/25741005 | PubMed |
| 11 | 30587523 | Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis. | Mol Cancer Res | 2019 | https://conductscience.org/library/papers/30587523 | PubMed |
| 12 | 35169141 | Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer. | Nat Commun | 2022 | https://conductscience.org/library/papers/35169141 | PubMed |
| 13 | 27094534 | CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos. | Hum Gene Ther | 2016 | https://conductscience.org/library/papers/27094534 | PubMed |
| 14 | 26792800 | In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens. | J Immunol | 2016 | https://conductscience.org/library/papers/26792800 | PubMed |
| 15 | 6951197 | Molecular genetics of vaccinia virus: demonstration of marker rescue. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6951197 | PubMed |
| 16 | 30300041 | Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines. | Expert Rev Vaccines | 2018 | https://conductscience.org/library/papers/30300041 | PubMed |
| 17 | 21886163 | Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. | Nature | 2011 | https://conductscience.org/library/papers/21886163 | PubMed |
| 18 | 26780180 | Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. | Nat Biotechnol | 2016 | https://conductscience.org/library/papers/26780180 | PubMed |
| 19 | 33833439 | The cGAS-STING pathway as a therapeutic target in inflammatory diseases. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33833439 | PubMed |
| 20 | 32483165 | Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. | Nat Commun | 2020 | https://conductscience.org/library/papers/32483165 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42196288 | Therapeutic Innovations for Monkeypox Inhibition. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196288 | PubMed |
| 41957020 | Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs. | Nat Commun | 2026 | https://conductscience.org/library/papers/41957020 | PubMed |
| 41675688 | Identification and evaluation of novel intergenic sites in the vaccinia virus genome for transgene insertion. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/41675688 | PubMed |
| 40789743 | Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40789743 | PubMed |
| 40725333 | CRISPR/Cas9-Mediated Knockout of the Corazonin Gene Indicates Its Regulation on the Cuticle Development of Desert Locusts (Schistocerca gregaria). | Insects | 2025 | https://conductscience.org/library/papers/40725333 | PubMed |
| 40143547 | Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation. | Mol Ther | 2025 | https://conductscience.org/library/papers/40143547 | PubMed |
| 39726634 | Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine. | Front Genome Ed | 2024 | https://conductscience.org/library/papers/39726634 | PubMed |
| 39621264 | Cas9-Mediated Poxvirus Recombinant Recovery (CASPRR) for Fast Recovery of Recombinant Vaccinia Viruses. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/39621264 | PubMed |
| 39609558 | Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses. | Nat Biomed Eng | 2025 | https://conductscience.org/library/papers/39609558 | PubMed |
| 39179564 | Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy. | Nat Commun | 2024 | https://conductscience.org/library/papers/39179564 | PubMed |
| 38139802 | At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38139802 | PubMed |
| 38022679 | Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022679 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36713447
GET https://conductscience.org/api/papers/v1/36713447/authors?page=2